contact us: sales@mouthswabdrugtests.com

Free shipping on all orders over $75.00

How Specimen Validity Testing Protects a Workplace Drug Testing Program

A drug test result is usually talked about in simple terms. Positive or negative. Pass or fail. But before a lab ever gets to that question, it runs a separate check that has nothing to do with drugs at all. That check is called specimen validity testing, and it exists to answer a more basic question first: is this actually a genuine human specimen, collected the way it was supposed to be collected?

For employers running a testing program, understanding specimen validity testing matters because it explains where some of the most confusing lab results come from. An employee’s test can come back neither positive nor negative. It can come back dilute, substituted, adulterated, or invalid, and each of those outcomes means something different and calls for a different response. Treating them all the same is one of the more common mistakes employers make when a result doesn’t fit the usual positive or negative pattern.

What Specimen Validity Testing Actually Checks

Specimen validity testing is a set of laboratory checks run on every specimen, separate from the screening and confirmation tests that look for drugs or their metabolites. The goal is to confirm the specimen is consistent with normal human physiology and hasn’t been diluted, substituted, or chemically altered in a way that would interfere with accurate drug testing.

For a urine specimen, labs typically check creatinine concentration and specific gravity, which together indicate whether the sample is consistent with normal urine or has been diluted with water or another liquid. They also test pH and look for the presence of oxidizing adulterants, substances someone might add to a specimen specifically to interfere with drug detection.

Oral fluid specimens are checked differently, since the biology is different. Under federal rules governing DOT-regulated testing, laboratories testing oral fluid specimens are required to test for a biomarker, such as albumin or immunoglobulin G, that confirms the fluid is actually human oral fluid, or to test for a specific adulterant known to interfere with results. The U.S. Department of Transportation’s Office of Drug and Alcohol Policy and Compliance lays out these requirements for oral fluid validity testing directly in the federal regulation governing transportation workplace testing programs.

The point of all of this is the same regardless of specimen type. A drug test result is only meaningful if the lab can trust that what it tested was a genuine, unadulterated specimen collected the way the program’s procedures require.

The Four Outcomes Beyond Positive and Negative

Specimen validity testing can produce four distinct findings that sit outside the normal positive and negative categories.

A dilute result means the specimen has lower-than-expected creatinine and specific gravity, usually consistent with the person having consumed a large amount of fluid before testing. This is not automatically suspicious. People drink more water than usual for all kinds of ordinary reasons, and a dilute result on its own is not treated as evidence of an attempt to beat the test.

A substituted result means the specimen’s characteristics are inconsistent with human urine or oral fluid altogether, suggesting the specimen submitted wasn’t actually produced by the person being tested.

An adulterated result means a foreign substance was detected that is known to interfere with testing, indicating something was added to the specimen after it left the body.

An invalid result means the specimen’s physical or chemical properties are inconsistent with normal human specimen characteristics in a way that doesn’t clearly point to substitution or adulteration. It’s often caused by something like unusual pH or an unidentified interfering substance, and it’s a distinct finding from the other three, not a milder version of any of them.

Each of these outcomes has real consequences and a defined process behind it, but they are not interchangeable, and an employer or supervisor who treats a dilute result the same way they’d treat an adulterated one is making a mistake that can create its own liability.

Why This Process Exists

Specimen validity testing exists to protect the integrity of the testing process itself, not to catch people in the act of trying to beat a test. Most dilute and even some invalid results trace back to ordinary causes that have nothing to do with intent. But the testing has to be able to detect the small number of cases where a specimen genuinely isn’t what it claims to be, because a program that can’t distinguish a real specimen from a tampered one can’t produce results anyone can trust, including the employer relying on them and the employee whose job may depend on them.

This is also where collection method matters more than most employers realize. Oral fluid collection, when properly observed, happens directly in front of the collector from start to finish. There’s no private stall, no running water, and no opportunity to introduce an outside substance between the moment the specimen leaves the body and the moment it’s sealed. That structural difference doesn’t make validity testing unnecessary, labs still run the full battery of checks, but it does mean fewer of the substitution and adulteration scenarios that specimen validity testing exists to catch are realistically available during an observed oral fluid collection in the first place.

What Happens When a Specimen Doesn’t Pass

In a DOT-regulated program, when a laboratory reports a specimen as adulterated, substituted, or invalid, the finding goes to the Medical Review Officer, who reviews it against the specific criteria in the regulations before it’s reported to the employer. For an invalid result, the MRO typically has the option to contact the employee for a possible medical explanation before deciding how the case should be handled, which can include directing an immediate, directly observed recollection.

For employers, the practical guidance here is straightforward. Don’t guess at what an unusual result means before the MRO process runs its course. A non-negative screening result, a dilute finding, and an adulterated or substituted finding all require different handling, and none of them should be interpreted or discussed by a supervisor before it’s been through proper review. Treating the full MRO review process as the gate for any employment action, rather than acting on a preliminary lab finding, is what keeps a program defensible if a decision is ever questioned later.

Documentation matters just as much here as it does anywhere else in a testing program. If a recollection is required, the timeline and the reason for it should be written down as it happens, not reconstructed afterward. If an employee offers a medical explanation for a dilute or invalid result, that explanation and how it was evaluated should be part of the record, even when the outcome doesn’t change. SAMHSA’s own workplace drug testing resources page is a useful general reference for employers who want to see how these program elements fit together outside of the DOT-specific rules.

A Common Misconception Worth Addressing

One misconception employers sometimes carry is that any non-standard result, dilute, invalid, or otherwise, implies the employee did something wrong. In reality, specimen validity testing exists precisely because labs need a reliable way to tell the difference between ordinary biological variation and genuine specimen tampering. A dilute result from someone who drank a lot of water before a test is a completely different situation from a substituted specimen, even though both fall outside the simple positive or negative framework. Programs that train supervisors and HR staff to understand that distinction, rather than treating every unusual result as equally serious, avoid a lot of unnecessary friction with employees and avoid the appearance of jumping to conclusions before the process is complete.

Where This Fits Into the Bigger Picture

Specimen validity testing is a reminder that a drug testing program’s credibility depends on more than just the panel of substances it screens for. It depends on the lab being able to vouch for the specimen itself, and on the employer understanding that a non-standard finding isn’t automatically a red flag. Programs that use a straightforward, closely observed collection method, like a mouth swab drug test, start that process with fewer points of vulnerability than methods that rely on private collection settings. Pairing that kind of collection approach with a clear understanding of what the lab’s validity findings actually mean is part of what keeps a testing program both fair to employees and defensible when results are ever questioned.

Sources

  • U.S. Department of Transportation, Office of Drug and Alcohol Policy and Compliance: 49 CFR 40.93, What validity tests must laboratories conduct on primary oral fluid specimens? https://www.transportation.gov/odapc/part40/40-93
  • SAMHSA: Workplace Drug Testing Resources, https://www.samhsa.gov/substance-use/drug-free-workplace/drug-testing-resources
Leave a Reply

Your email address will not be published. Required fields are marked *

Free Fast Shipping

On all orders above $75

Trusted Quality

Quality Assurance Guaranteed

Customers Worldwide

Thousands of Happy Customers

100% Secure Checkout

PayPal / MasterCard / Visa